Peak Pharma Cash Flow - Quarterly (OTCMKTS:PKPH)

Add to My Stocks
$0.13 $0 (0%) PKPH stock closing price Sep 21, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like Peak Pharma needs to disclose. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Peak Pharma profits one has to check the income statement and for Peak Pharma debt one has to check the balance sheet. Peak Pharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Peak Pharma had cash and cash equivalents of $- at the beginning of the quarter and $- at quarter end for 2018 Q3. Peak Pharma has a negative cash and cash equivalents change of $-.

View and download details of Peak Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Net Income Cash Flow
-0.02M-0.01M-0.01M-0.05M-0.02M-0.01M-1.16M--
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-0.01M-------0.08M--
Cash From (used in) Discontinued Operations----------
Other Adjustments Net--------1.29M--
Net Cash from (used by) Operating Activities
-0.02M-0.02M--0.01M-0.01M---0.2M-0.2M-0.19M
Increase (Decrease) in Prop Plant And Equipment----------
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
----------
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
----------
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
--------0.2M-0.2M-0.19M
Cash & Equivalents at Beginning of Year----------
Cash & Equivalents at Year End----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Peak Pharma stock price history provides insight into historical stock price fluctuations, and Peak Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Peak Pharma had a Net Change in Cash and Cash Equivalents of $- in the latest quarter 2018 Q3. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Peak Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Peak Pharma decreased its cash from operating activities to $-0.02M till 2018 Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash from investing stood at a negative value of $- for PKPH stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $- for Peak Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Peak Pharma Cash Flow

Quarterly Cash Flow Statements For Peak Pharmaceuticals Inc Peers

MYOS RENS cash flow, Protalex cash flow